Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8801
PUT
Ultragenyx Pharmaceutical
RARE
$2.51B
| $377K | ﹤0.01% |
9,400
-7,800
| -45% | -$335K |
|
8802
Tompkins Financial
TMP
$1.44B
| $377K | ﹤0.01% |
5,692
-16,044
| -74% | -$1.18M |
|
|
CTLP
8803
PUT
DELISTED
Cantaloupe
CTLP
| $377K | ﹤0.01% |
66,100
+45,700
| +224% | +$243K |
|
8804
Superior Group of Companies
SGC
$200M
| $377K | ﹤0.01% |
47,871
+20,440
| +75% | +$220K |
|
8805
CALL
Sundial Growers
SNDL
$306M
| $377K | ﹤0.01% |
235,450
-324,300
| -58% | -$636K |
|
8806
PUT
iShares Russell 3000 ETF
IWV
$20.2B
| $377K | ﹤0.01% |
1,600
-700
| -30% | -$162K |
|
8807
SiriusPoint
SPNT
$2.74B
| $376K | ﹤0.01% |
46,299
+18,311
| +65% | +$129K |
|
8808
CALL
Old National Bancorp
ONB
$10.2B
| $376K | ﹤0.01% |
26,100
+18,600
| +248% | +$315K |
|
|
CTO
8809
PUT
CTO Realty Growth
CTO
$819M
| $376K | ﹤0.01% |
21,800
+7,500
| +52% | +$136K |
|
8810
RBB Bancorp
RBB
$461M
| $376K | ﹤0.01% |
24,271
-28,166
| -54% | -$539K |
|
8811
CALL
VanEck Steel ETF
SLX
$174M
| $376K | ﹤0.01% |
5,900
-500
| -8% | -$32.3K |
|
8812
CALL
FormFactor
FORM
$9.71B
| $376K | ﹤0.01% |
11,800
+300
| +3% | +$8.6K |
|
8813
CALL
State Street SPDR S&P Kensho New Economies Composite ETF
KOMP
$2.76B
| $376K | ﹤0.01% |
8,800
+8,100
| +1,157% | +$345K |
|
8814
Avantis Short-Term Fixed Income ETF
AVSF
$654M
| $376K | ﹤0.01% |
+8,106
| New | +$374K |
|
8815
CALL
SELLAS Life Sciences
SLS
$2.65B
| $376K | ﹤0.01% |
262,600
-67,800
| -21% | -$168K |
|
|
ITI
8816
DELISTED
Iteris, Inc.
ITI
| $375K | ﹤0.01% |
+80,062
| New | +$335K |
|
|
ACH
8817
CALL
Accendra Health
ACH
$86.9M
| $375K | ﹤0.01% |
25,800
-42,100
| -62% | -$754K |
|
8818
CALL
Upland Software
UPLD
$13.4M
| $375K | ﹤0.01% |
8,730
+690
| +9% | +$47.8K |
|
8819
CALL
Seres Therapeutics
MCRB
$43.6M
| $375K | ﹤0.01% |
3,310
+275
| +9% | +$29.7K |
|
|
NAPA
8820
CALL
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $375K | ﹤0.01% |
23,600
+700
| +3% | +$11K |
|
8821
PUT
Playboy Inc
PLBY
$141M
| $375K | ﹤0.01% |
189,500
+40,500
| +27% | +$101K |
|
8822
United States Lime & Minerals
USLM
$3.38B
| $375K | ﹤0.01% |
+12,285
| New | +$374K |
|
8823
IDEX
IEX
$17.3B
| $375K | ﹤0.01% |
1,623
-772
| -32% | -$175K |
|
8824
Caesarstone
CSTE
$114M
| $375K | ﹤0.01% |
90,762
+33,050
| +57% | +$183K |
|
|
FBZ
8825
DELISTED
First Trust Brazil AlphaDEX Fund
FBZ
| $375K | ﹤0.01% |
38,742
+4,027
| +12% | +$42.2K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.